Yifat Hen Zommer - Net Worth and Insider Trading

Yifat Hen Zommer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yifat Hen Zommer owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .

Click here to see the complete history of Yifat Hen Zommer’s form 4 insider trades.

Insider Ownership Summary of Yifat Hen Zommer

Ticker Comapny Transaction Date Type of Owner
ORMP Oramed Pharmaceuticals Inc 2009-04-19 CFO & TREASURER AND SECRETARY

Yifat Hen Zommer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Yifat Hen Zommer Ownership Network

Ownership Network List of Yifat Hen Zommer

No Data

Ownership Network Relation of Yifat Hen Zommer

Insider Network Chart

Yifat Hen Zommer Owned Company Details

What does Oramed Pharmaceuticals Inc do?

Who are the key executives at Oramed Pharmaceuticals Inc?

Yifat Hen Zommer is the CFO & TREASURER AND SECRETARY of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .

Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oramed Pharmaceuticals Inc Insider Transactions

No Available Data

Yifat Hen Zommer Mailing Address

Above is the net worth, insider trading, and ownership report for Yifat Hen Zommer. You might contact Yifat Hen Zommer via mailing address: 20 Tarad, Ramat Gan L3 52503.

Discussions on Yifat Hen Zommer

No discussions yet.